4CPS-038 Initial experience with the use of pcsk9-inhibitors in the real-world clinical practice
Author(s) -
Sandra Koprivnik,
Amparo Martı́nez,
Isaura Rodríguez Penín
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.129
Subject(s) - medicine , prior authorization , evolocumab , statin , pcsk9 , pharmacy , medical prescription , alirocumab , medical record , clinical trial , intensive care medicine , emergency medicine , family medicine , pharmacology , cholesterol , lipoprotein , ldl receptor , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom